Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf593 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Emily S Clark und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Sylvester Comprehensive Cancer Center, Miller School of Medicine.
Abstract (Originalsprache)
CD8+ T-cell responses are an important component of a protective immune response in many pathogenic infections, including HIV and Herpesviridae such as cytomegalovirus (CMV) and Epstein-Barr virus (EBV). Identification of pathogen-encoded protective antigens, antigenic heterogeneity, and progressive immune dysfunction are major barriers facing the development of effective CD8+ T-cell–targeted vaccines. Here we tested the hypothesis that pathogen-infected cells can be sensitized to vaccination against host-derived antigens presented by the infected cells with reduced expression of TAP (transporter associated with antigen processing). In this study, we show the following: first, natural or targeted downregulation of TAP in CMV- and EBV- or HIV-infected cells, respectively, leads to the presentation of a cell-encoded nonmutated cryptic epitope, initially described in tumor cells with reduced TAP expression; second, peripheral blood mononuclear cell–derived CD8+ T cells enriched for multiple TAP downregulation–induced epitopes recognize TAPlow CMV-, EBV-, and HIV-infected cells, leading to the depletion of TAPlow-infected cells and the expression of activation markers in the T cells. This study describes a prototype of a universal drug formulation to vaccinate against tumors and pathogen-infected cells, dispensing with the need to identify pathogen- or tumor-specific antigenic targets and obviating the limitations associated with antigenic heterogeneity and immune dysfunction characteristic of pathogens such as HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology.
- Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida.
ORCID-Profile: Eli Gilboa
Förderung
- NIAID NIH HHS
- Sylvester Comprehensive Cancer Center
- Miller School of Medicine
Zitieren
APA
Clark, E. S., Garrido, G., Levay, A., Schrand, B., & Gilboa, E. (2026). Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf593
Vancouver
Clark ES, Garrido G, Levay A, Schrand B, Gilboa E. Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf593
BibTeX
@article{Clark2026,
author = {Clark, Emily S and Garrido, Greta and Levay, Agata and Schrand, Brett and Gilboa, Eli},
title = {Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf593}
}
EUVIMED